Vimarsana
Biggest News Aggregation in the World

Brock Analysis Test News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brock Analysis Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brock Analysis Test Today - Breaking & Trending Today

CNN Erin Burnett OutFront May 17, 2013 03:21:00 - Vimarsana News

CNN Erin Burnett OutFront May 17, 2013 03:21:00

Years in the project. that investment is paying off. the brock analysis test costs $4,000, often covered by insurance. and made up 82% of the company's revenue in fiscal 2012. the company's profit, $112 million. this biotech analyst has followed myriad for a decade. >> are they going to stop researchers from using their work? no. but the idea is if someone else tries to do what they're doing kplertially, they have to be protected. that's the critical difference. >> reporter: myriad argue that's patented genes encourages innovation and investment and hasn't prevented research. others disagree. ...

CNN Erin Burnett OutFront May 17, 2013 06:21:00 - Vimarsana News

CNN Erin Burnett OutFront May 17, 2013 06:21:00

Can genes or synthetic genes be patented or are they products of nature that shouldn't be owned by anyone? >> this case is such a big deal because so many people think the future of medicine is genetics. and how the law regards genes and synthetic genes will dictate how and whether companies invest to find new cures. >> reporter: myriad says it invested $500 million over 17 years in the project. that investment is paying off. the brock analysis test costs $4,000, often covered by insurance. and made up 82% of the company's revenue in fiscal 2012. the company's profit, $112 million. this biotec...

CNN Erin Burnett OutFront May 16, 2013 23:25:00 - Vimarsana News

CNN Erin Burnett OutFront May 16, 2013 23:25:00

That investment is paying off. the brock analysis test costs $4,000, often covered by insurance. and made up 82% of the company's revenue in fiscal 2012. the company's profit, $112 million. this biotech analyst has followed myriad for a decade. >> are they going to stop researchers from using their work? no. but the idea is if someone else tries to do what they're doing kplertially, they have to be protected. that's the critical difference. >> reporter: myriad argue that's patented genes encourages innovation and investment and hasn't prevented research. others disagree. >> we're at the cusp o...